Skip to main content

Table 6 Patients’ biological profile at day 7 post treatment

From: Efficacy and tolerability of a new formulation of artesunate-mefloquine for the treatment of uncomplicated malaria in adult in Senegal: open randomized trial

 

AM

AL

p value

 

Day 7

Day 7

 

Mean haemoglobin

11.3 ± 1.8

10.6 ± 1.5

0.11

Anaemia (%)

86 (54.7%)

105 (68.6%)

0.01

Median ALAT

19

19.3

0.93

Median ASAT

24

25

0.53

Patients with ASAT < 40 (%)

143 (91%)

139 (90.8%)

0.94

Patients with ALAT < 40 (%)

146 (92.9%)

145 (94.7%)

0.51

Mean creatinine

7.7 ± 4.7

8.2 ± 7.0

0.50

Patients with normal level of creatinine (%)

149 (94.9%)

150 (98.0%)

0.13

Median bilirubin

1.10

1.08

0.36

Patients with normal level of bilirubin (%)

92 (58.6%)

82 (53.6%)

0.37